Figure 2.
Bubble chart displaying 14 occlusive events that occurred from 2012 to 2017 in 85 patients treated with different doses of ponatinib. The diameter of the area of the bubble represent the dose of ponatinib (15, 30, or 45 mg)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.